R4 Ballot #1 #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: (v3.5.0: R4 Ballot 2). #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Plandefinition-opioidcds-10

Clinical Decision Support Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Not linked to any defined compartments

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile PlanDefinition .

Generated Narrative with Details

id : opioidcds-10

url : http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-10

identifier : cdc-opioid-guidance (OFFICIAL)

version : 0.1.0

name : cdc-opioid-10

title : CDC Opioid Prescribing Guideline Recommendation #10

type : ECA Rule (Details : {http://hl7.org/fhir/plan-definition-type {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status : draft

date : 23/04/2017

publisher : Centers for Disease Control and Prevention (CDC)

description : When prescribing opioids for chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.

useContext : ,

jurisdiction : United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose : CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage : Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.

copyright : © CDC 2016+.

topic : Opioid Prescribing (Details )

contributor author : , , ,

relatedArtifact :

library : Library/opioidcds-recommendation-10

action

title : Annual Urine Screening Check

description : Patient has not had a urine screening in the past 12 months

documentation :

trigger :

Conditions

- Kind Description Language Expression
* applicability Patient has not had a urine screening in the past 12 months text/cql No Screenings in Past Year

DynamicValues

- Path Expression
* activity.extension Get Indicator

Actions

-
*
*

action

title : Positive Urine Screening Check

description : Patient has a urine screening testing positive for either unprescribed opioids or illicit drugs in the past 12 months

documentation :

Conditions

- Kind Description Language Expression
* applicability Patient has a positive urine screening in the past 12 months text/cql Has Positive Screening?

Actions

-
*
*
*

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.